1.2400
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-6,105.5700
-6,105.5700
-2,910.6040
-2,627.2980
-1,798.4040
Investing Cash Flow
-31.9410
-31.9410
-420.2540
-938.9530
-169.6820
Financing Cash Flow
4,449.3110
4,449.3110
-110.1440
8,777.6400
3,212.0220
End Cash Position
1,247.6010
1,247.6010
2,532.7580
6,840.9690
1,812.2990
Capital Expenditure
-117.2850
-117.2850
-428.9450
-817.9980
-173.0470
Issuance of Capital Stock
5,088.0760
5,088.0760
--
--
35.0700
Issuance of Debt
--
--
--
12,000.0000
3,609.9760
Repayment of Debt
--
--
--
-3,183.2810
--
Free Cash Flow
-6,222.8550
-6,222.8550
-3,339.5490
-3,445.2960
-1,971.4510
12/31/2020 - 1/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INBX Inhibrx Biosciences, Inc.
13.55
+10.07%
MRNS Marinus Pharmaceuticals, Inc.
0.5406
-0.48%
APLS Apellis Pharmaceuticals, Inc.
30.39
+3.12%
ENTX Entera Bio Ltd.
2.3300
-2.10%
QNCX Quince Therapeutics, Inc.
1.6000
-2.44%
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
NFX.L Nuformix plc
0.0750
-11.76%
IMUX Immunic, Inc.
1.0200
+3.03%
ANTX AN2 Therapeutics, Inc.
1.1700
-0.85%
JSPR Jasper Therapeutics, Inc.
6.70
+15.92%